Replies to post #793851 on NorthWest Biotherapeutics Inc (NWBO)

[maverick_1]

Underscores a larger trend retrenched investment across the CGT industry, as companies confront steep manufacturing cost, scalability hurdles & uncertain commercial returns

The sector has seen sharp pullback with investment pivoting towards lower-risk, later-stage programmes

— maverick_1 (@maveric92283613) October 22, 2025

DIFFERENT STROKES for DIFFERENT FOLKS